Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar 28;11(12):1833-6.
doi: 10.3748/wjg.v11.i12.1833.

Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer

Fan-Ping Meng  1 , Jie Ding, Zhao-Cai Yu, Quan-Li Han, Chang-Cun Guo, Na Liu, Dai-Ming Fan
Affiliations

Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer

Fan-Ping Meng et al. World J Gastroenterol. .

Abstract

Aim: To develop an oral attenuated Salmonella typhimurium vaccine against gastric cancer and to evaluate its efficacy in mice.

Methods: A complementary sequence of Nco I site and a sequence coding for MG7-Ag mimotope were designed at the 5' terminus of forward primer. Using p1.2 II-HBCAg plasmid as template, PCR was performed to get a fusion gene of the mimotope and a HBcAg gene. The fusion gene was then subcloned into the plasmid pYA3341 complementary to Salmonella typhimurium X4550, and the recombinant plasmid was then transformed into attenuated Salmonella typhimurium X4550. Balb/c mice were orally immunized with the recombinant Salmonella typhimurium X4550. The mice were immunized every 2 wk to reinforce the immunity. At the 6th wk, serum titer of antibody was detected by ELISA, and at the 8th wk, cellular immunity was detected by (51)Cr release test. Ehrlich ascites carcinoma cells expressing MG7-Ag were used in tumor challenge assay as a model to evaluate the protective effect of the vaccine.

Results: Serum titer of antibody against MG7-Ag was significantly higher in mice immunized with the vaccine than in control groups (0.9538+/-0.043 vs 0.6531+/-0.018, P<0.01; 0.9538+/-0.043 vs 0.6915+/-0.012, P<0.01), while in vitro (51)Cr release assay of the splenocytes showed no statistical difference in the three groups. Two weeks after tumor challenge, 1 in 5 immunized mice was tumor free, while all the mice in the control group presented tumor.

Conclusion: Oral attenuated Salmonella typhimurium vaccine against the MG7-Ag mimotope of gastric cancer is immunogenic. It can induce significant humoral immunity against tumors in mice, and has some protective effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incorporation of the MG7 epitope cDNA into HBcAg gene by PCR. An about 600 bp fragment was obtained (1,2). Lane M: DNA marker (100-3000 bp); lanes 1-2: the PCR product.
Figure 2
Figure 2
Identification of fusion gene vaccine. Lane M: DNA marker (100-3000 bp); lanes 1,2: the digestion product.
Figure 3
Figure 3
Western blot of the expression product of MG7/HBcAg fusion gene. Lane M: Protein marker (Mr); lane 1: X4550 transformed with empty pYA3341; lanes 2,3: X4550 transformed with pYA3341-MG7/HBcAg (after induction of IPTG for 2 and 4 h).
See this image and copyright information in PMC

References

    1. Liu J, Hu JL, Zhang XY, Qiao TD, Chen XT, Wu KC, Ding J, Fan DM. The value of MG7 antigen in predicting cancerous change in dysplastic gastric mucosa. Int J Clin Pract. 2002;56:169–172. - PubMed
    1. Xu L, Qiao T, Chen B. Mimic epitope recognized by monoclonal antibody MG7 against gastric cancer through screening phage displayed random peptide library. Zhonghua YiXue ZaZhi. 2000;80:304–307. - PubMed
    1. Xu L, Xu H, Ma F. Immunogenicity of phage-displayed tumor antigen-mimic peptide. Zhonghua ZhongLiu ZaZhi. 2001;23:187–189. - PubMed
    1. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655–692. - PubMed
    1. Shikhman AR, Cunningham MW. Trick and treat: toward peptide mimic vaccines. Nat Biotechnol. 1997;15:512–513. - PubMed

Publication types

MeSH terms